Lenalidomide丨CAS 191732-72-6

Lenalidmide丨191732-72-6 is a synthetic derivative f thalidmide, belnging t the class f immunmdulatry drugs (IMiDs). It is used primarily in the treatment f hematlgical cancers and autimmune diseases due t its ability t mdify the immune system and target cancer cells.

1. Treatment f Hematlgical Cancers
● Multiple Myelma:
Lenalidmide is cmmnly used in the treatment f multiple myelma either alne r in cmbinatin with ther therapies like dexamethasne and brtezmib. It is cnsidered a standard therapy fr this cnditin.
● Myeldysplastic Syndrmes (MDS):
It is als used t treat myeldysplastic syndrmes with del(5q) chrmsmal abnrmalities, imprving the red bld cell cunt and quality f life fr patients.
● Mantle Cell Lymphma:
Lenalidmide is used in the treatment f mantle cell lymphma, especially in relapsed r refractry cases.
2. Autimmune Diseases
● Lupus and Rheumatid Arthritis:
In certain cases, lenalidmide is used t treat autimmune disrders like systemic lupus erythematsus (SLE) and rheumatid arthritis, due t its ability t mdulate immune respnses.
● Granulmatsis with Plyangiitis:
It is used as an experimental treatment fr granulmatsis with plyangiitis, an autimmune cnditin that affects small bld vessels.
3. Clinical Research and Trials
● Investigatinal Use:
Lenalidmide is currently being investigated in clinical trials fr ther types f cancers, autimmune diseases, and chrnic inflammatry cnditins.

1. Effective Anti-Cancer Prperties
● Lenalidmide丨191732-72-6 wrks by mdulating the immune system, enhancing the bdy's ability t attack cancer cells, particularly in cnditins like multiple myelma and mantle cell lymphma.
2. Imprved Quality f Life in Cancer Patients
● It reduces symptms and imprves verall quality f life fr patients with bld cancers by lwering the need fr transfusins and prmting red bld cell prductin in MDS.
3. Immune System Mdulatin
● Lenalidmide enhances immune respnses by increasing T-cell functin and prducing cytkines, which play a critical rle in the fight against cancer and autimmune diseases.
4. ral Administratin and Cnvenience
● It is administered rally, prviding cnvenience ver intravenus therapies, which is an advantage fr lng-term treatment regimens.
5. Brad Applicatins in Cancer and Autimmune Disrders
● Lenalidmide has shwn prmise in treating varius cancers and autimmune cnditins, and its research cntinues t uncver additinal ptential uses.

Lenalidmide丨191732-72-6 is an imprtant immunmdulatry drug with effective applicatins in treating hematlgical cancers like multiple myelma and myeldysplastic syndrmes. It als shws prmise in autimmune disease management. Its ability t mdulate the immune system, target cancer cells, and imprve patient utcmes makes it a vital therapeutic tl in mdern medicine.